標(biāo)題: Titlebook: Additive Manufacturing in Pharmaceuticals; Subham Banerjee Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive lice [打印本頁] 作者: Motion 時間: 2025-3-21 17:16
書目名稱Additive Manufacturing in Pharmaceuticals影響因子(影響力)
書目名稱Additive Manufacturing in Pharmaceuticals影響因子(影響力)學(xué)科排名
書目名稱Additive Manufacturing in Pharmaceuticals網(wǎng)絡(luò)公開度
書目名稱Additive Manufacturing in Pharmaceuticals網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Additive Manufacturing in Pharmaceuticals被引頻次
書目名稱Additive Manufacturing in Pharmaceuticals被引頻次學(xué)科排名
書目名稱Additive Manufacturing in Pharmaceuticals年度引用
書目名稱Additive Manufacturing in Pharmaceuticals年度引用學(xué)科排名
書目名稱Additive Manufacturing in Pharmaceuticals讀者反饋
書目名稱Additive Manufacturing in Pharmaceuticals讀者反饋學(xué)科排名
作者: investigate 時間: 2025-3-22 00:00 作者: artless 時間: 2025-3-22 03:45 作者: NUDGE 時間: 2025-3-22 07:47
Stereolithography (SLA) in Pharmaceuticals,zed cats. The L6 dorsal root was given 1 to 500Hz stimuli, and the CAPs were recorded from the L2 dorsal column. The L4 cord segment was compressed by stepped increments (0.5mm/5min.) until the responses at 1Hz disappeared. Before compression, each CAP at all frequencies showed almost uniform amplit作者: 獨行者 時間: 2025-3-22 09:25
Selective Laser Sintering (SLS) in Pharmaceuticals,spond. The ’ contingent negative variation’ (CNV) was the first discovered example of this (Walter et al. 1964). Similar pre-event potentials were found in a variety of delayed reaction paradigms, in both man (Low et al. 1966a; Donchin et al. 1971, 1972; Kutas and Donchin 1980; Rohrbaugh et al. 1980作者: 委屈 時間: 2025-3-22 13:24 作者: 形容詞詞尾 時間: 2025-3-22 17:33
Inkjet and Binder Jet Printing in Pharmaceuticals,ung, im adulten Normalzustand mit seiner Anpassungsf?higkeit (i. e., Lernprozessen) zum Zwecke der Optimierung individuellen Verhaltens, sowie der postl?sionell reaktiv neuroplastischen Vorg?nge erschien es bedeutsam, die bereits intensiv auf das Gehirn ausgerichteten Untersuchungen (vgl. Benowitz u作者: lymphoma 時間: 2025-3-22 21:23 作者: 脫落 時間: 2025-3-23 02:37 作者: CROAK 時間: 2025-3-23 06:58
Bioprinting in Pharmaceuticals,last likely the most common form of light-induced damage, since the natural range of light energy sufficient causative. Photochemical damage is caused by reactive oxygen species and free radicals generated by light exposure, also called photooxidative stress. Although different types of photooxidati作者: Bumptious 時間: 2025-3-23 13:22 作者: 不足的東西 時間: 2025-3-23 16:24
Machine Learning in Additive Manufacturing of Pharmaceuticals,rojections, the number of dementia cases will dramatically rise from 13.5 million cases in 2000 to 21.2 million in 2025 and 36.7 million in 2050. Medical advancements have increased human life expectancy and led to a rise in neurodegenerative disorders, which pose a growing social and economic burde作者: avenge 時間: 2025-3-23 21:33
Book 2023al AM. This book is indeed a valuable resource for students, researchers/scholars, young start-ups/entrepreneurs, and pharmaceutical professionals by providing thorough detailing about AM in Pharmaceuticals..作者: Cpr951 時間: 2025-3-24 00:51 作者: Pcos971 時間: 2025-3-24 03:39
https://doi.org/10.1007/978-981-19-5658-4chloramphenicol, prednisolone, aspirin, and berberine have been successfully 3D printed. In addition, soft devices for drug release have also been 3D printed. However, unexpected reactions have been reported in the literature which emphasize the cautionary aspect of 3D printing pharmaceuticals using作者: Acetaldehyde 時間: 2025-3-24 08:41
Multiprotocol Label Switching (MPLS),ine-tuning of various process parameters. An added benefit of this powder bed fusion technology is that, it allows the fabrication of any solid oral dosage form in just a single step without use of any solvent, which turns this technique of rapid prototyping into green technology. Thus, the purpose 作者: Rotator-Cuff 時間: 2025-3-24 11:03
Advanced Encryption Standard (AES),ameters of the printing process, such as printing speed, infill pattern and number of layers. Due to this versatility, SSE has become a powerful tool to produce innovative dosage forms with clinical relevance for specific groups, including paediatric, geriatric and veterinary populations, as persona作者: GIST 時間: 2025-3-24 17:10 作者: 樂章 時間: 2025-3-24 22:07 作者: 一再遛 時間: 2025-3-24 23:20 作者: Jogging 時間: 2025-3-25 06:13 作者: painkillers 時間: 2025-3-25 09:29
Cryosurgery of Advanced External Cancerecent articles about 3D printed medicine and the application of machine learning. We also include recent articles about 3D printed medicine that use statistical approaches in the experimental methods. Finally, we discuss a possible future where “artificial intelligence pharmacists” will regularly us作者: acrimony 時間: 2025-3-25 13:50 作者: fatty-acids 時間: 2025-3-25 16:41
Front Mattermodernen Verfahren der funktionellen und strukturellen Bildgebung nur sehr begrenzte M?glichkeiten, um Einblick in die Funktion bzw. Dysfunktion des ZNS zu gewinnen. CCT (Craniale Computer Tomographie) und MRT (Magnetresonanztomographie) liefern mit hoher r?umlicher Aufl?sung Information über die Hi作者: ANN 時間: 2025-3-25 21:26
History and Present Scenario of Additive Manufacturing in Pharmaceuticals,urteilen ist der unter dem Begriff ?brainstem death gemeinte Sachverhalt einer irreversiblen Zerst?rung des Hirnstamms mit - partiell - erhaltener Gro?hirnt?tigkeit (sichtbar z. B. in EEG-Aktivit?t oder erhaltenen visuell evozierten Potentialen). Hier gilt, da? durch den Ausfall der aufsteigenden ak作者: BROOK 時間: 2025-3-26 00:46 作者: flimsy 時間: 2025-3-26 07:17
Stereolithography (SLA) in Pharmaceuticals,however, the amplitude increased and the latency decreased. And they reached to almost steady level. In conclusion, the inability to transmit impulses at high stimulus frequencies indicates incomplete impairment of spike generation in the CNS fibers injured by compression. And it may be that the imp作者: Ardent 時間: 2025-3-26 10:22 作者: Bravura 時間: 2025-3-26 13:49
Semi-Solid Extrusion (SSE) in Pharmaceuticals,daptive potential. Indeed, it has been suggested that altered or impaired neuroplasticity may contribute to a variety of pathological states associated with dysregulation of mood [.]. Thus, the goal of this chapter is to focus on glutamate’s role in neuroplasticity in brain structures associated wit作者: Seminar 時間: 2025-3-26 20:44
Inkjet and Binder Jet Printing in Pharmaceuticals,AP-43-Antik?rper; eine detaillierte Darstellung des anatomischen Normalsubstrats und der GAP-43 Expression im Rückenmark adulter und sich postnatal entwickelnder Ratten; die Untersuchung der Ver?nderung der GAP-43-Expression von descendierenden und ascendierenden Projektions-Neuronen, propriospinale作者: 拱墻 時間: 2025-3-27 00:43 作者: anesthesia 時間: 2025-3-27 01:06
4D Printing in Pharmaceuticals,cations..An essential prerequisite for the successful use of a neuroprosthesis is a preserved neural innervation of muscles. The strength-duration curve allows for quantitative evaluation of denervation of muscle fibers. A profound knowledge of the neurophysiological principles underlying electrical作者: CORE 時間: 2025-3-27 09:20 作者: ineptitude 時間: 2025-3-27 10:30 作者: 光滑 時間: 2025-3-27 17:05 作者: palpitate 時間: 2025-3-27 21:16 作者: 利用 時間: 2025-3-28 01:03 作者: Duodenitis 時間: 2025-3-28 03:28 作者: 成份 時間: 2025-3-28 06:16 作者: Tempor 時間: 2025-3-28 13:08
Advanced Encryption Standard (AES),oming the most explored technique to obtain solid dosage forms with specific characteristics, such as chewable, fast-dissolving or gastro-floating tablets, polypills, oral and topical films, and rectal suppositories, among others. The advantages of SSE include a low work temperature, with less risk 作者: aptitude 時間: 2025-3-28 17:02
https://doi.org/10.1007/978-981-10-8306-8is interest is ., which holds a unique position due to the early regulatory precedents established using this technology and also the diversity of materials it can process..To date, binder jetting is the only type of additive manufacturing worldwide to be part of an approved drug application, first 作者: 先行 時間: 2025-3-28 21:50 作者: heterogeneous 時間: 2025-3-29 01:13 作者: athlete’s-foot 時間: 2025-3-29 06:22 作者: eustachian-tube 時間: 2025-3-29 07:57
Cryosurgery of Advanced External Cancerength, quality, and purity. Generally, the regulatory pathway to be followed in obtaining marketing authorization does not change with a manufacturing method employed in preparing a drug product or a device. New drug application can be submitted via 505(b)(1) or 505(b)(2) regulatory pathway, while a作者: anthesis 時間: 2025-3-29 15:13 作者: MIME 時間: 2025-3-29 19:20
Subham BanerjeePresents applications, potential, and the challenges of additive manufacturing in pharmaceuticals.Discusses different aspects of pharmaceutical 3D printing platform technologies.Examines the regulator
